Kelly Spill’s life changed in an instant when she was diagnosed with stage III rectal cancer at just 28 years old. But it wasn’t the diagnosis itself that brought her to tears. It was the thought of having her life upended forever—potentially losing the ability to have more children and facing the need for a colostomy bag after surgery.

The emotional breaking point came when she asked her doctor about a planned elopement to Switzerland with her fiancé, only to be told, “Oh, absolutely not.” That moment made her realize that everything she envisioned for the future was now uncertain.

Fast forward five years, and Kelly is not only cancer-free but also expecting her third child. This incredible turn of events is thanks to a groundbreaking cancer treatment: immunotherapy.

Immunotherapy Changes Lives

Kelly’s journey took a positive turn when she was offered a chance to join a clinical trial using the immunotherapy drug dostarlimab, developed by GSK and marketed under the name Jemperli. This treatment, which harnesses the body’s own immune system to target and eliminate cancer cells, helped Kelly avoid the aggressive chemotherapy, radiation, and surgery that were initially recommended.

Dostarlimab has already shown promise in earlier research, even earning designation as a “breakthrough therapy” by the FDA for treating certain rectal cancers. But a new study, published in The New England Journal of Medicine, reveals the drug’s potential to treat various cancer types effectively, allowing patients to bypass surgery and avoid more invasive treatments.

Kelly’s experience is a testament to this innovation. After just nine treatments, her tumor had completely disappeared. “I was told I didn’t need surgery or radiation, and that was the best day of my life,” she says. “It felt like a miracle.”

A Life-Changing Treatment for Many

The study included 117 patients with different types of solid tumors, including rectal, colon, gastric, bladder, and prostate cancers. The key factor was that these patients had mismatch repair-deficient (dMMR) tumors, which are more likely to respond to immune-based treatments.

Dr. William Dahut, chief scientific officer at the American Cancer Society, explains the science behind it: “With DNA repair deficiencies, patients often have more mutations, which makes their tumors more vulnerable to immunotherapy.”

This study found that 80% of participants treated with dostarlimab saw their tumors vanish without needing surgery, chemotherapy, or radiation. Even more remarkable, these patients were able to lead normal lives, with their organs intact. Some women even went on to conceive and give birth—something that would not have been possible with traditional treatments.

The Future of Cancer Treatment

While the results of this trial are groundbreaking, researchers caution that larger studies are necessary to confirm the long-term benefits, especially for patients with non-rectal cancers. However, the findings mark a significant shift in cancer care, moving away from invasive surgeries and toxic treatments.

Dr. Andrea Cercek, a gastrointestinal oncologist, calls it a “game-changer” for patients. “We can eliminate cancer with minimal side effects, leaving patients feeling well and living normal lives,” she says.

This marks a new era of cancer treatment, where immunotherapy is not just an option but potentially the future. As Dr. Stacey Cohen from Fred Hutchinson Cancer Center points out, the era of non-operative cancer care could soon become the new standard, offering hope for patients with cancers previously deemed too difficult to treat without surgery.

A Call for Early Detection

For Kelly Spill, the decision to join a clinical trial was life-altering. But her experience also highlights a critical issue: early detection of colorectal cancer in younger adults. The American Cancer Society reports a troubling rise in colorectal cancer cases among people under 55, with the proportion increasing from 11% in 1995 to 20% in 2019.

Kelly urges others to trust their instincts and advocate for themselves. “Don’t wait. If something doesn’t feel right, push for answers,” she says. She recalls the moment when blood in her stool led to her diagnosis, emphasizing the importance of being proactive, especially for young adults who may overlook symptoms.

Looking Ahead

As immunotherapy continues to evolve, researchers are optimistic about its potential to treat a wide range of cancers, not just rectal cancer. While not all patients respond equally to the treatment, its promise in reducing the need for surgery and improving quality of life is undeniable.

For Kelly, the journey from cancer diagnosis to pregnancy and remission has been nothing short of extraordinary. “Take a deep breath and trust the timing,” she advises, reflecting on the hurdles she’s overcome. “You never know what treatment might change your life.”

This groundbreaking study offers hope to many, with the possibility of a future where cancer is treated with less invasive methods and more effective results, changing the landscape of cancer care for the better.

Source: CNN – Immunotherapy helps certain cancer patients avoid surgery: ‘We hope this is the future’

The post How Immunotherapy is Changing Cancer Treatment for Good appeared first on Journos News - Breaking News, World News, Top Stories, Todays Headlines and Flash Reports.

Michael Bolton is facing one of the toughest challenges of his life — and he’s opening up with honesty and resilience.

The 72-year-old Grammy-winning singer revealed in a recent People interview that he was diagnosed with glioblastoma, an aggressive and incurable form of brain cancer, in late 2023. The diagnosis followed emergency surgery to remove a brain tumor in December. Just a month later, Bolton had to undergo a second brain surgery due to an infection.

Despite the difficult journey, Bolton has continued to fight with determination and optimism. He completed both chemotherapy and radiation treatments in October 2024 and now undergoes regular MRIs every two months to monitor for any recurrence.

“Succumbing to the challenge is not an option,” Bolton said. “You’re really quickly drawn into a duel. I guess that’s the way you find out what you’re made of.”

According to the Cleveland Clinic, glioblastoma is the most common malignant brain tumor in adults and grows rapidly, though it rarely spreads beyond the brain and spinal cord. The prognosis is often grim — without treatment, life expectancy can be less than six months. Still, treatments can help slow the progression and manage symptoms.

Bolton admitted the physical and emotional toll has been significant. He’s experienced challenges with short-term memory, speech, and mobility, but he hasn’t let it define him. Instead, he’s focused on recovery and maintaining strength — with the help of a personal trainer and voice therapist.

More than anything, the singer finds strength in his support system.

“Just to know that you’re not alone going through it is a big deal,” he said. “It actually helps people to know. It reminds them that they’re not alone.”

Bolton’s family has been by his side throughout his battle, and he’s using this time to deepen those relationships, especially with his children. He’s more reflective than ever about the legacy he wants to leave behind.

“How do I give things that they can take forward? Life lessons, love, any kind of validation — I want to be on the right side of that so they feel great about who they are,” he shared.

Rather than focus on the odds or statistics, Bolton is choosing to live in the moment and remain hopeful.

“It’s unthinkable for it to be okay not to make the most of your life,” he said. “You have to be a cheerleader for yourself.”

His daughter, Taryn Bolton, echoed that sentiment:

“We’re in this together, and that’s it.”

As he continues his journey, Bolton hopes his openness helps others facing similar battles feel less alone — and more empowered to keep fighting.

Source: Today – Michael Bolton reveals glioblastoma diagnosis: ‘You find out what you’re made of’

The post Michael Bolton Reveals Brain Cancer Diagnosis and His Fight to Stay Strong appeared first on Journos News - Breaking News, World News, Top Stories, Todays Headlines and Flash Reports.